Preferred test to follow-up presumptive results. For general screening, Phencyclidine, Urine Screen with Reflex to Quantitation (2012265) is preferred.
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Transport 1 mL urine. (Min: 0.5 mL)
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years (Avoid repeated freeze/thaw cycles)
Effective August 17, 2015
|Drugs Covered||Cutoff Concentrations|
Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry.
Positive cutoff: 10 ng/mL.
For medical purposes only; not valid for forensic use.
The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Compare to Pain Management, Phencyclidine, Quantitative, with medMATCH, Urine; Pain Management, Phencyclidine, with Confirmation with medMATCH, Urine.
83992 (Alt code: G0480)
|Component Test Code*||Component Chart Name||LOINC|
|2010463||Phencyclidine (PCP), Urn, Quant||3937-0|